Skip to main content
logo
CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3710
+0.0010 (0.27%)
At close: Jun 9, 2026, 4:00 PM EDT
0.3700
-0.0010 (-0.27%)
After-hours: Jun 9, 2026, 6:58 PM EDT

CollPlant Biotechnologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.392.370.5210.960.315.64
Revenue Growth (YoY)
-84.26%360.39%-95.30%3565.22%-98.09%154.86%
Cost of Revenue
0.960.841.631.990.42.01
Gross Profit
-0.571.54-1.118.97-0.113.64
Selling, General & Admin
1.194.835.636--
Research & Development
1.688.1910.5210.48--
Total Operating Expenses
2.8713.0216.1416.4800
Operating Income
6.5911.4817.257.5117.10.07
Total Non-Operating Income (Expense)
-0.18-0.010.640.490.170.17
Pretax Income
6.4111.4817.898.0117.270.24
Net Income
6.4111.4817.898.0117.270.24
Net Income to Common
6.4411.4916.617.0216.930.24
Net Income Growth
-33.31%-30.83%136.63%-58.53%7041.35%-
Shares Outstanding (Basic)
131211111110
Shares Outstanding (Diluted)
131211111112
Shares Change (YoY)
11.52%6.54%0.57%3.23%-7.80%73.76%
EPS (Basic)
-0.47-0.94-1.45-0.62-1.530.02
EPS (Diluted)
-0.47-0.94-1.45-0.62-1.530.02
Free Cash Flow
-7.64-9.45-14.58-3.72-14.971.07
Free Cash Flow Per Share
-0.60-0.77-1.27-0.33-1.360.09
Gross Margin
-147.56%64.78%-215.53%81.83%-33.78%87.18%
Operating Margin
1695.12%484.31%3349.71%68.55%5718.06%0.42%
Profit Margin
1647.81%484.06%3474.37%73.05%5775.59%1.52%
FCF Margin
-1964.14%-398.44%-2830.29%-33.92%-5007.36%6.86%
EBITDA
7.4712.418.298.6118.170.84
EBITDA Margin
1920.82%522.78%3551.26%78.60%6077.93%5.36%
EBIT
6.5911.4817.257.5117.10.07
EBIT Margin
1695.12%484.31%3349.71%68.55%5718.06%0.42%
SEC Filings: 10-K · 10-Q